Berberine Treat Metabolic Syndrome in Schizophrenia

Clinical trial NCT03251716 · COMPLETED

Trial details

NCT number: NCT03251716
Sponsor: Tianjin Anding Hospital
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Metabolic Syndrome Female Schizophrenia

Start date: 2015-01-01
Primary completion: 2017-10-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.